Z-β-丙氨酸甲酯 | 54755-77-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: Z-β-丙氨酸甲酯
• 英文名称: methyl 3-(benzyloxycarbonylamino)propanoate
• 英文别名: N-Benzyloxycarbonyl-β-alanin-methylester；Methyl 3-([(benzyloxy)carbonyl]amino)propanoate；methyl 3-(phenylmethoxycarbonylamino)propanoate
• CAS: 54755-77-0
• 化学式: C₁₂H₁₅NO₄
• mdl: MFCD00270495
• 分子量: 237.255
• InChiKey: LWSYHFSVQUXZJI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2924299090
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-([(benzyloxy)carbonyl]amino)propanoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-([(benzyloxy)carbonyl]amino)propanoate
CAS number: 54755-77-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H15NO4
Molecular weight: 237.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  Z-β-丙氨酸甲酯 在 sodium hydroxide 作用下， 生成 N-CBZ-beta-丙氨酸
  参考文献：
  名称：

  Über β-Isocyanat-fettsäureester und einige ihrer Reaktionsprodukte

  摘要：

  DOI：

  10.1007/bf00900623
• 作为产物：
  描述：

  N-CBZ-beta-丙氨酸 在 乙醚 、 五氯化磷 作用下， 生成 Z-β-丙氨酸甲酯
  参考文献：
  名称：

  Sifferd; du Vigneaud, Journal of Biological Chemistry, 1935, vol. 108, p. 753,756

  摘要：

  DOI：

文献信息

• Arylethynyl derivatives
  申请人：Green Luke

  公开号：US20110251169A1

  公开（公告）日：2011-10-13

  The present invention relates to ethynyl compounds of formula I wherein R1, R2, R2′, R3, R3′, R4, R4′, U, V, W, Y, m, and n are as defined herein and to a pharmaceutically acceptable acid addition salts, to a racemic mixtures, or to its corresponding enantiomers and/or optical isomers and/or stereoisomers thereof. Compounds of formula I are allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).

  本发明涉及式I的乙炔基化合物，其中R1、R2、R2′、R3、R3′、R4、R4′、U、V、W、Y、m和n如本文所述，以及药用可接受的酸加成盐，或其对映体和/或光学异构体和/或立体异构体的相应外消旋混合物。式I的化合物是代谢型谷氨酸受体5亚型（mGluR5）的变构调节剂。
• COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY
  申请人：PROTEOSTASIS TEHRAPEUTICS, INC.

  公开号：US20170001993A1

  公开（公告）日：2017-01-05

  The invention encompasses compounds such as compounds having the Formula (I) or (II), compositions thereof, and methods of modulating CFTR activity. The invention also encompasses methods of treating a condition associated with CFTR activity or condition associated with a dysfunction of proteostasis comprising administering to a subject an effective amount of a disclosed compound.

  这项发明涵盖了诸如具有化学式(I)或(II)的化合物、这些化合物的组合物以及调节CFTR活性的方法。该发明还涵盖了治疗与CFTR活性相关的疾病或与蛋白质稳态功能障碍相关的疾病的方法，包括向受试者施用所披露化合物的有效量。
• Synthesis and Evaluation of Chirally Defined Side Chain Variants of 7-Chloro-4-Aminoquinoline To Overcome Drug Resistance in Malaria Chemotherapy
  作者：Vasantha Rao Dola、Awakash Soni、Pooja Agarwal、Hafsa Ahmad、Kanumuri Siva Rama Raju、Mamunur Rashid、Muhammad Wahajuddin、Kumkum Srivastava、W. Haq、A. K. Dwivedi、S. K. Puri、S. B. Katti

  DOI：10.1128/aac.01152-16

  日期：2017.3

  A novel 4-aminoquinoline derivative [( S )-7-chloro- N -(4-methyl-1-(4-methylpiperazin-1-yl)pentan-2-yl)-quinolin-4-amine triphosphate] exhibiting curative activity against chloroquine-resistant malaria parasites has been identified for preclinical development as a blood schizonticidal agent. The lead molecule selected after detailed structure-activity relationship (SAR) studies has good solid-state properties and promising activity against in vitro and in vivo experimental malaria models. The in vitro absorption, distribution, metabolism, and excretion (ADME) parameters indicate a favorable drug-like profile.

  摘要 一种新型 4-氨基喹啉衍生物 [( S )-7-氯- N -(4-甲基-1-(4-甲基哌嗪-1-基)戊烷-2-基)-喹啉-4-胺三磷酸酯]对耐氯喹的疟原虫具有治疗活性，已被确定作为血吸虫杀灭剂进行临床前开发。经过详细的结构-活性关系（SAR）研究后选出的先导分子具有良好的固态特性，对 体外 和 体内 实验疟疾模型具有良好的活性。体外 体外 吸收、分布、代谢和排泄（ADME）参数表明其具有良好的类药物特征。
• [EN] ARYLETHYNYL DERIVATIVES<br/>[FR] DÉRIVÉS D'ARYLÉTHYNYLE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011128279A1

  公开（公告）日：2011-10-20

  The present invention relates to ethynyl derivatives of formula (I) as allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5). The variables in formula (I) are defined in the specification.

  本发明涉及式(I)的乙炔衍生物，作为代谢型谷氨酸受体亚型5（mGluR5）的别构调节剂。式(I)中的变量在说明书中有定义。
• Arginase Inhibitors and Their Therapeutic Applications
  申请人：OncoArendi Therapeutics S.A.

  公开号：US20170319536A1

  公开（公告）日：2017-11-09

  Disclosed are small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. Also disclosed are pharmaceutical compositions comprising the compounds, and methods for using the compounds for treating or preventing a disease or condition associated with arginase activity.

  揭示了一种小分子治疗化合物，它们是较强的精氨酸酶1和精氨酸酶2活性抑制剂。还揭示了包含这些化合物的药物组合物，以及使用这些化合物治疗或预防与精氨酸酶活性相关的疾病或状况的方法。